About Xilio Therapeutics (XLO)
Xilio Therapeutics, Inc. is a biotechnology company. The Company is focused on harnessing the immune system to achieve clinical responses for cancer patients. It offers a geographically precise solutions (GPS) platform to engineer molecules, includin... Read more
- USD0.76
- USD0.78
- USD0.74
- USD1.70
- 5.70%
- 6M
- 114.22k
- 195.29k
- 43M
- 0.62
- -26.40%
Stock News
3 hours ago
China says ‘door is open’ for trade talks with U.S., sending stock futures higher
MarketWatch
yesterday
Block shares plunge 17% on revenue miss
CNBC
yesterday
The Federal Savings Bank Partners with Blend to Power a Faster Mortgage Refinance Experience for Borrowers
Yahoo
yesterday
Spin purgatory: How DuPont and Honeywell shares have battled ahead of their splits
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
